AP Celgene is acquiring Juno Therapeutics, a company developing personalized cancer treatments in a deal worth $ 9 billion. It’s the second deal in 2018 for the biotech giant, which has been under pressure from investors. The highly personalized treatments Juno makes, called CAR T-cell therapy, are at the beginning of what some are calling “a big […]
